UNSPSC 51453010: Piperazine estrone sulfate

This classification denotes an antihelminthic agent with the molecular formula C18H22O5S.C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SVI38UY019, chemically known as estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1), but more generally known as piperazine estrone sulfate, which bears US NIH Compound Identifier 23703. European Medicines Agency schedules piperazine estrone sulfate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG.

Most nations, for tariff purposes, schedule piperazine estrone sulfate under HS 29335990. SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CCC2=O)OS(=O)(=O)O.C1CNCCN1.

UNSPSC 51453010 Piperazine estrone sulfate is a Commodity code that nominally designates pharmaceutical active ingredients, yet the recent state and local contract activity tagged to this code shows no purchasing aligned with that specific chemical compound. Instead, the opportunities posted under this code reflect broader pharmaceutical procurement — specifically antibiotics (Doxycycline Hyclate, Ciprofloxacin Hydrochloride) and emergency response medications (Naloxone) — suggesting that state and local procurement offices are using this code as a placeholder or catchall for pharmaceutical supply contracts rather than purchasing piperazine estrone sulfate specifically. The issuing bodies include state health departments and county health authorities, both of which are active in direct pharmaceutical procurement through cooperative purchasing vehicles and competitive bidding.

The geographic spread of recent activity centers on Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026, under IFB 26482DPHPREPDB53392, with a 12-month initial term and two optional renewal years. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford; that bid closed July 26, 2026. The code shows limited recent activity and the pharmaceutical products actually being purchased do not match the code's nominal scope, indicating either systematic miscoding or a jurisdictional practice of consolidating pharmaceutical commodity purchases under a single UNSPSC designation.